Currently Viewing:
SGO Annual Meeting on Women's Cancer
Dr Martha Gaines: Turning Experience as Cancer Survivor into Patient Advocacy
April 20, 2018
Dr Sean C. Dowdy Discusses Improving Surgical Outcomes in Gynecologic Oncology
April 18, 2018
Dr William Cliby: Patient Factors and Surgery, Quality of Care For Ovarian Cancer
April 16, 2018
Currently Reading
Dr Anna Beavis Highlights Importance of Addressing Gender Gaps in HPV Vaccination
April 15, 2018
Dr Victoria Bae-Jump Discusses Standard of Care, Novel Therapies For Endometrial Cancer
April 11, 2018
Dr Sean C. Dowdy: Reducing Opioid Abuse in Patients Undergoing Surgery for Gynecologic Malignancies
April 04, 2018
Study Models ASCO Alternative Payment Model in Advanced Ovarian Cancer Care
March 27, 2018
Study Explores Mechanism Linking Statin to Reduced Tumor Size in Endometrial Cancer
March 26, 2018
Dr Oliver Dorigo on New, Innovative Therapies in Gynecologic Cancers
March 26, 2018
Dr William Cliby Explains Predictors of Patient Outcomes in Ovarian Cancer
March 26, 2018
Putting PARP Inhibitor Perspectives Into Practice in "Beyond the Guidelines" Session
March 26, 2018
Dr Anna Beavis Discusses Gender Differences in HPV Vaccination
March 25, 2018
Dr Victoria Bae-Jump on Obesity and Endometrial Cancer
March 25, 2018
Boys Don't Get HPV Vaccination Because Doctors Don't Recommend It, Study Finds
March 25, 2018
Deciding When to Use PARP Inhibitors, and Which One
March 25, 2018
Dr Scott Page: Diversity in Healthcare Improves Patient Outcomes
March 25, 2018
Clinical Trials Can Reduce Disparities in Advanced Ovarian Cancer, but Funding Is Needed, Researchers Say
March 25, 2018
Dr Martha Gaines Discusses the Importance of the Patient Voice
March 25, 2018

Dr Anna Beavis Highlights Importance of Addressing Gender Gaps in HPV Vaccination

If we don't close the gap in gender differences in HPV vaccination, we will likely see an increase in HPV-related cancers, explained Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.


If we don't close the gap in gender differences in HPV vaccination, we will likely see an increase in HPV-related cancers, explained Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.

Transcript

What consequence will we see if gender differences in HPV vaccination are not addressed?

If we don’t close the gap in the HPV vaccination disparity that we see by gender in the United States, then we’ll likely still see a reduction in cervical cancer, but not as big a reduction we could see if we vaccinated both boys and girls. For both boys and girls, cancer of the mouth and throat, as well as anal cancers, that are associated with HPV, those will continue to increase. We’re already seeing an increase in those HPV-related cancers, especially in boys.

Are there any efforts you see right now aimed at closing these gaps?

Yes. There are a multitude of efforts. Some are at the state level, some are at the healthcare system level, some at the physician level, and others are at the community level. I think it’s going to take a very diverse and varied approach at all of these levels in order to improve vaccination rates.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!